机构：[1]Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu 610041, China.四川大学华西医院[2]Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Chengdu 610041, China.[3]Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.四川大学华西医院[4]Faculty of Dentistry, The University of Hong Kong, Prince Philip Dental Hospital, Hong Kong 999077, China.
The 70 kDa heat shock proteins (HSP70s) are a group of highly conserved and inducible heat shock proteins. One of the main functions of HSP70s is to act as molecular chaperones that are involved in a large variety of cellular protein folding and remodeling processes. HSP70s are found to be over-expressed and may serve as prognostic markers in many types of cancers. HSP70s are also involved in most of the molecular processes of cancer hallmarks as well as the growth and survival of cancer cells. In fact, many effects of HSP70s on cancer cells are not only related to their chaperone activities but rather to their roles in regulating cancer cell signaling. Therefore, a number of drugs directly or indirectly targeting HSP70s, and their co-chaperones have been developed aiming to treat cancer. In this review, we summarized HSP70-related cancer signaling pathways and corresponding key proteins regulated by the family of HSP70s. In addition, we also summarized various treatment approaches and progress of anti-tumor therapy based on targeting HSP70 family proteins.
基金：
This study was supported by grants from the National Natural Science Foundation of China
(Grant No. 82203153 to K.Z. and Grant No. 31771549 to Y.C.) and the Natural Science Foundation of
Sichuan Province (Grant 2022NSFSC1438 to J.Z.).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类|2 区生物学
小类|3 区生化与分子生物学
最新[2023]版：
大类|2 区生物学
小类|3 区生化与分子生物学
第一作者：
第一作者机构：[1]Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu 610041, China.[2]Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Chengdu 610041, China.
共同第一作者：
通讯作者：
通讯机构：[1]Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu 610041, China.[2]Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Chengdu 610041, China.
推荐引用方式(GB/T 7714)：
Zhao Kejia,Zhou Guanyu,Liu Yu,et al.HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances[J].Biomolecules.2023,13(4):doi:10.3390/biom13040601.
APA：
Zhao Kejia,Zhou Guanyu,Liu Yu,Zhang Jian,Chen Yaohui...&Zhang Gao.(2023).HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances.Biomolecules,13,(4)
MLA：
Zhao Kejia,et al."HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances".Biomolecules 13..4(2023)
